Russo J, Thompson M I, Russo M E, Saxon B A, Matsen J M, Moody F G, Rikkers L F
Antimicrob Agents Chemother. 1982 Sep;22(3):488-92. doi: 10.1128/AAC.22.3.488.
The concentrations of piperacillin in serum, bile, gallbladder wall, abdominal skeletal muscle, and adipose tissue were measured simultaneously at various times after the intravenous administration of a single 5-g dose to each of 14 patients undergoing biliary tract surgery. Piperacillin concentrated in the bile with peak levels exceeding 4,000 micrograms/ml. In a single patient with cystic duct obstruction, trace gallbladder bile piperacillin levels were measured. Gallbladder wall concentrations of piperacillin tended to be higher than corresponding serum concentrations, with a correlation observed between tissue values and the degree of acute gallbladder inflammation and gallbladder bile piperacillin concentrations. Mean peak muscle and adipose tissue piperacillin concentrations of 31 and 27 micrograms/g, respectively, were reached at between 2 and 3 h after the start of infusion. These concentrations exceeded the minimum inhibitory concentration for a majority of susceptible organisms. A single 5-g dose of piperacillin achieved therapeutic levels in gallbladder wall, intraabdominal skeletal muscle, and adipose tissue and concentrated in the bile of patients with patent biliary tracts.
对14例接受胆道手术的患者,每人静脉注射单次5克剂量的哌拉西林后,在不同时间同时测定血清、胆汁、胆囊壁、腹部骨骼肌和脂肪组织中哌拉西林的浓度。哌拉西林在胆汁中浓缩,峰值水平超过4000微克/毫升。在1例胆囊管梗阻患者中,测定到胆囊胆汁中哌拉西林的微量水平。哌拉西林在胆囊壁中的浓度往往高于相应的血清浓度,组织值与急性胆囊炎程度和胆囊胆汁哌拉西林浓度之间存在相关性。输注开始后2至3小时,肌肉和脂肪组织中哌拉西林的平均峰值浓度分别达到31微克/克和27微克/克。这些浓度超过了大多数敏感菌的最低抑菌浓度。单次5克剂量的哌拉西林在胆囊壁、腹内骨骼肌和脂肪组织中达到治疗水平,并在胆道通畅的患者胆汁中浓缩。